I content index at the end of the present report. Consolidated annual financial statement 
(sections 3:23, 3:31 and 3:32, of the BCAC) 
INCOME STATEMENT 
IBA reported a 18.7% increase in revenues to 
EUR 428.7 million during 2023 (2022: EUR 
361.3 million), which is shown with a growth on 
both equipments and services sales. Despite a 
slow backlog conversion for Proton Therapy, the 
revenue of other accelerators increased thanks 
Delegated regulation obligations, article 8 annex II Template 1 N